Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin-21 receptor (IL-21R) is a type I cytokine receptor that plays a crucial role in the immune system by mediating the effects of its ligand, interleukin-21 (IL-21). It is essential for the proliferation, differentiation, and function of T cells, B cells, and natural killer (NK) cells. Dysregulation or aberrant signaling through this pathway has been implicated in autoimmune diseases due to excessive immune activation. Conversely, therapeutic targeting/modulation holds promise for cancer immunotherapy because it can enhance anti-tumor immunity via effects on cytotoxic lymphocytes.
Targeting/modulation holds promise for cancer immunotherapy; Blocking IL-21R signaling may be beneficial in autoimmune diseases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-21 Receptor.